Mark Roest Selected Research

Mark Roest Research Topics

Disease

17	Thrombosis (Thrombus) 02/2024 - 07/2002
8	Hemorrhage 02/2024 - 03/2014
7	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 02/2005
5	Neoplasms (Cancer) 02/2024 - 01/2018
5	Inflammation (Inflammations) 01/2022 - 03/2005
5	Stroke (Strokes) 01/2022 - 12/2003
5	Sepsis (Septicemia) 01/2020 - 01/2017
5	Myocardial Infarction 03/2015 - 04/2006
5	Breast Neoplasms (Breast Cancer) 12/2005 - 11/2003
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 06/2006 - 02/2005
3	Malaria 01/2022 - 12/2010
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2021 - 12/2004
3	Thrombocytopenia (Thrombopenia) 12/2021 - 08/2013
3	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 09/2017 - 04/2014
3	Pre-Eclampsia (Preeclampsia) 02/2016 - 04/2008
3	Ischemic Stroke 03/2015 - 08/2005
3	Coronary Disease (Coronary Heart Disease) 08/2011 - 04/2006
2	Hypertension (High Blood Pressure) 02/2024 - 11/2009
2	Fibrosis (Cirrhosis) 10/2023 - 01/2020
2	Critical Illness (Critically Ill) 12/2022 - 01/2020
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 07/2002
2	Convalescence 01/2022 - 01/2020
2	Infections 01/2022 - 01/2017
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2021 - 03/2014
2	HELLP Syndrome 12/2021 - 04/2008
2	Hemolysis 12/2021 - 04/2008
2	Vascular Diseases (Vascular Disease) 05/2015 - 08/2005
2	Thrombotic Microangiopathies 01/2015 - 03/2014
2	Hemophilia A (Haemophilia) 06/2014 - 06/2011
2	Carotid Artery Diseases 03/2005 - 06/2004
1	Hypercholesterolemia 02/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024
1	COVID-19 12/2022
1	Polyps 01/2022
1	Parasitemia 01/2022
1	Multiple Myeloma 01/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2021
1	Purpura 12/2021

Drug/Important Bio-Agent (IBA)

13	Thrombin FDA Link 02/2024 - 01/2018
10	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2004
8	P-SelectinIBA 01/2022 - 06/2011
7	Aryldialkylphosphatase (Paraoxonase)IBA 08/2008 - 06/2004
6	von Willebrand FactorIBA 01/2022 - 09/2013
5	EnzymesIBA 12/2021 - 06/2004
4	AnticoagulantsIBA 01/2022 - 05/2015
4	IronIBA 04/2006 - 08/2003
3	Thromboplastin (Tissue Factor)IBA 12/2023 - 12/2021
3	IntegrinsIBA 10/2022 - 03/2015
3	Fibrinolysin FDA Link 01/2022 - 03/2014
3	CollagenIBA 01/2022 - 01/2012
3	C-Reactive ProteinIBA 01/2021 - 03/2005
3	HDL CholesterolIBA 02/2016 - 03/2005
3	Adenosine Diphosphate (ADP)IBA 03/2015 - 09/2012
3	AntibodiesIBA 03/2014 - 12/2004
3	HDL LipoproteinsIBA 06/2006 - 06/2004
3	oxidized low density lipoproteinIBA 03/2005 - 06/2004
2	thiamine triphosphorate (TTP)IBA 02/2024 - 12/2021
2	Indicators and Reagents (Reagents)IBA 02/2024 - 02/2016
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022 - 03/2014
2	FibrinIBA 01/2022 - 01/2021
2	AntigensIBA 01/2022 - 01/2020
2	Inosine Triphosphate (ITP)IBA 12/2021 - 03/2014
2	LigandsIBA 01/2021 - 02/2016
2	fibrin fragment D (D-dimer)IBA 01/2021 - 04/2005
2	SelectinsIBA 01/2017 - 09/2013
2	Interleukin-6 (Interleukin 6)IBA 02/2016 - 04/2008
2	ChemokinesIBA 07/2014 - 01/2014
2	Glycoproteins (Glycoprotein)IBA 06/2014 - 03/2014
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2014
2	Fibrinogen (Factor I)FDA Link 01/2013 - 04/2008
2	Antiphospholipid AntibodiesIBA 11/2009 - 12/2004
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 11/2009 - 12/2004
2	Transferrin (beta 2 Transferrin)IBA 04/2006 - 08/2005
2	Ferritins (Ferritin)IBA 04/2006 - 08/2005
2	Estrogen Receptor alphaIBA 12/2005 - 11/2005
2	factor V LeidenIBA 04/2005 - 07/2002
1	Contraceptive Agents (Contraceptives)IBA 02/2024
1	CoagulantsIBA 11/2023
1	ThrombomodulinIBA 10/2023
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 12/2022
1	PAR-1 ReceptorIBA 12/2022
1	Factor XII (Hageman Factor)IBA 01/2022
1	Protein CIBA 01/2022
1	Ellagic AcidIBA 01/2022
1	KaolinIBA 01/2022
1	Kallikreins (Kallikrein)IBA 01/2022
1	VaccinesIBA 01/2022
1	PolyphosphatesIBA 01/2022
1	APTIBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 12/2021
1	COVID-19 VaccinesIBA 12/2021
1	platelet membrane glycoprotein VIIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Factor XIIIaIBA 01/2021

Therapy/Procedure

3	Critical Care (Surgical Intensive Care) 12/2022 - 09/2017
2	Therapeutics 01/2022 - 01/2018
2	Central Venous Catheters 04/2005 - 07/2002
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2005 - 07/2002